Cetrimide

Cetrimide, or alkyltrimethylammonium bromide, is an antiseptic which is a mixture of three quaternary ammonium compounds: tetradonium bromide (TTAB or MITMAB), cetrimonium bromide (CTAB), and laurtrimonium bromide (DTAB or LTAB).[1] It was first discovered and developed by ICI and introduced under the brand name Cetavlon.[2] It is used as a 1-3 % solution for cleaning roadside accident wounds.[3] ICI also introduced Savlon, which was a combination of cetrimide and chlorhexidine. ICI later sold the Savlon brand OTC to Johnson & Johnson in May 1992.[4]

Cetrimide
Identifiers
  • Compounds
  • Cetrimide: Mixture of
  • C17: Trimethyltetradecylammonium bromide
  • C16: Hexadecyltrimethylammonium bromide
  • C15: Dodecyltrimethylammonium bromide
ECHA InfoCard 100.118.908
EC Number
  • Cetrimide: 617-073-5
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

References
  1. Council of Europe (2007). European Pharmacopoeia (Ph. Eur.) (6.0 ed.). Strasbourg: The Stationery Office. pp. 1484–5. ISBN 978-92-871-6054-6. OCLC 170932841.
  2. "Archived copy". Archived from the original on 2013-10-05. Retrieved 2013-08-15.CS1 maint: archived copy as title (link)
  3. Tripathi, KD. Essentials of Medical Pharmacology (7th ed.). p. 900.
  4. http://www.thefreelibrary.com/JOHNSON+%26+JOHNSON+ACQUIRES+SAVLON+OTC+BRANDS+FROM+ICI-a012169404
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.